Work

A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)

Year: 2020

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2019.11.193

Authors: E.S. Yang, E. Deutsch, A. Mehmet, J. Fayette, L. Nabell, S.A. Spencer, M.C. Dobelbower, C.D. Willey, J.A. Bonner, X. Wang, A. Lin, W.N. William

Institutions: University of Alabama at Birmingham, Université Paris-Saclay, Institut Gustave Roussy, The University of Texas MD Anderson Cancer Center, Centre Léon Bérard, Eli Lilly (United States)

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3012276921

FWCI: 0.204

Cites:

Cited by: 1

Related to: 10